KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $22,062,000 | +62.2% | 122,700 | -6.5% | 0.02% | +54.5% |
| Q2 2017 | $13,598,000 | -59.1% | 131,170 | -69.0% | 0.01% | -63.3% |
| Q1 2017 | $33,238,000 | +958.2% | 423,468 | +504.6% | 0.03% | +900.0% |
| Q4 2016 | $3,141,000 | -42.5% | 70,038 | -28.4% | 0.00% | -40.0% |
| Q3 2016 | $5,465,000 | -42.5% | 97,857 | -48.5% | 0.01% | -54.5% |
| Q2 2016 | $9,498,000 | -72.5% | 189,953 | -74.8% | 0.01% | -75.0% |
| Q1 2016 | $34,540,000 | +0.2% | 752,348 | +34.5% | 0.04% | +15.8% |
| Q4 2015 | $34,465,000 | – | 559,319 | +55931800.0% | 0.04% | – |
| Q3 2015 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2015 | $157,000 | -85.9% | 2,568 | -86.7% | 0.00% | -100.0% |
| Q1 2015 | $1,116,000 | -72.9% | 19,349 | -72.9% | 0.00% | -75.0% |
| Q4 2014 | $4,123,000 | +412.2% | 71,497 | +153.0% | 0.00% | +300.0% |
| Q3 2014 | $805,000 | -28.9% | 28,257 | -27.8% | 0.00% | 0.0% |
| Q2 2014 | $1,132,000 | – | 39,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|